HMVJX
Price
$15.88
Change
+$0.06 (+0.38%)
Updated
Jul 16 closing price
Net Assets
1.13B
VMVIX
Price
$65.16
Change
+$0.31 (+0.48%)
Updated
Jul 16 closing price
Net Assets
30.57B
Interact to see
Advertisement

HMVJX vs VMVIX

Header iconHMVJX vs VMVIX Comparison
Open Charts HMVJX vs VMVIXBanner chart's image
Hartford MidCap Value I
Price$15.88
Change+$0.06 (+0.38%)
VolumeN/A
Net Assets1.13B
Vanguard Mid-Cap Value Index Investor
Price$65.16
Change+$0.31 (+0.48%)
VolumeN/A
Net Assets30.57B
HMVJX vs VMVIX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
HMVJX vs. VMVIX commentary
Jul 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HMVJX is a Hold and VMVIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VMVIX has more cash in the bank: 30.6B vs. HMVJX (1.13B). VMVIX pays higher dividends than HMVJX: VMVIX (2.14) vs HMVJX (0.91). HMVJX was incepted earlier than VMVIX: HMVJX (15 years) vs VMVIX (19 years). HMVJX (0.87) is less costly to investors than VMVIX (0.19). HMVJX is a more actively managed with annual turnover of: 132.00 vs. VMVIX (19.00). HMVJX has a lower initial minimum investment than VMVIX: HMVJX (2000) vs VMVIX (3000). VMVIX annual gain was more profitable for investors over the last year : 4.51 vs. HMVJX (-9.51). VMVIX return over 5 years is better than : 66.84 vs. HMVJX (32.16).
HMVJXVMVIXHMVJX / VMVIX
Total Expense Ratio0.870.19458%
Annual Report Gross Expense Ratio0.870.19458%
Fund Existence15 years19 years-
Gain YTD0.2531.89313%
Front LoadN/AN/A-
Min. Initial Investment2000300067%
Min. Initial Investment IRAN/AN/A-
Net Assets1.13B30.6B4%
Annual Yield % from dividends0.912.1443%
Returns for 1 year-9.514.51-211%
Returns for 3 years2.9626.9811%
Returns for 5 years32.1666.8448%
Returns for 10 years5.3284.016%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
INBX23.650.69
+3.01%
Inhibrx Biosciences Inc.
ALGS8.680.18
+2.12%
Aligos Therapeutics Inc
OCSL14.610.16
+1.11%
Oaktree Specialty Lending Corp
WTFCM25.00N/A
N/A
Wintrust Financial Corp
CMA61.14-0.09
-0.15%
Comerica